2021
DOI: 10.3390/genes13010080
|View full text |Cite
|
Sign up to set email alerts
|

Identification of Compound Heterozygous Variants in LRP4 Demonstrates That a Pathogenic Variant outside the Third β-Propeller Domain Can Cause Sclerosteosis

Abstract: Sclerosteosis is a high bone mass disorder, caused by pathogenic variants in the genes encoding sclerostin or LRP4. Both proteins form a complex that strongly inhibits canonical WNT signaling activity, a pathway of major importance in bone formation. So far, all reported disease-causing variants are located in the third β-propeller domain of LRP4, which is essential for the interaction with sclerostin. Here, we report the identification of two compound heterozygous variants, a known p.Arg1170Gln and a novel p.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 24 publications
0
2
0
Order By: Relevance
“…This variant is causal for sclerosteosis when present as heterozygous compound mutation together with another pathogenic variant in LRP4 (p.R1170Q). Cell-based assays confirmed how both of these mutations in LRP4 reduced receptor activity, providing support of the important function of the arginine also within the YWTD-domain of LRP4 [ 29 ]. We summarize these findings and literature in Table 3 .…”
Section: Resultsmentioning
confidence: 90%
“…This variant is causal for sclerosteosis when present as heterozygous compound mutation together with another pathogenic variant in LRP4 (p.R1170Q). Cell-based assays confirmed how both of these mutations in LRP4 reduced receptor activity, providing support of the important function of the arginine also within the YWTD-domain of LRP4 [ 29 ]. We summarize these findings and literature in Table 3 .…”
Section: Resultsmentioning
confidence: 90%
“…In previous work 25 , we identified 5 pathogenic variants in homologous proteins corresponding to substitution of an arginine at the YWTD-blade sequence position 38: one in LDLR: p.R595W LDLR in Familial hypercholesterolemia (FHCL1) patients 35 ; three in LRP5: p.R494Q LRP5 in patients with Osteoporosis-pseudoglioma (OPPG) 36,37 ; p.R752G LRP5 in a family with Exudative Vitreoretinopathy (EVR4) 38 ; and p.R1188W LRP5 , a variant that segregates with disease in large family pedigrees with Polycystic Liver Disease 4 (PCLD4) 39 ; and one in LRP4: p.R632H LRP4 that is causal of sclerosteosis and shows impaired activity documented by functional assays 40 .…”
Section: Variant Characterizationmentioning
confidence: 99%